US › Healthcare

Alector Inc (ALEC)

US · Healthcare · Biotechnology

$1.54+1.99%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$1.0M
Revenue YoY
-71.5%
Net profit
$-22.9M
Profit YoY
+43.3%
EPS
$-0.21
EPS estimate
$-0.27
Net margin
-2,192.2%

EPS came in at -0.21 against a street estimate of -0.27 — a beat of 22.2%.

Key statistics

Market cap
$167.6M
Forward P/E
8.5
P/B
16.15
Book value
$0.09
EPS (TTM)
$-1.19
52-week high
$3.40
52-week low
$1.09
50-day MA
$1.75
200-day MA
$1.88
Beta
0.60

Analyst view

Analysts rate Alector Inc a buy (6 buy, 1 hold, 2 sell out of 9) with an average price target of $3.10.

Shareholding

Insiders
9.67%
Institutions
82.22%

Largest institutional holders

FundStake
TCG Crossover Management, LLC9.01%
BlackRock Inc6.97%
Acadian Asset Management LLC3.64%
Foresite Capital Management IV, LLC3.50%
Vanguard Capital Management, LLC3.31%
Merck & Co Inc3.19%
D. E. Shaw & Co LP3.00%
683 Capital Management LLC2.88%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Alector Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.